Unknown OBSERVATIONAL NCT05095844

National Vaccine Adverse Event Reporting Survey and Etiology (NVAERS)

National Vaccine Adverse Event Reporting Survey to Determine the Etiology of Vaccine-Induced Injury

Sponsor: Neuroganics LLC

Conditions Blood Clot COVID-19 Corona Virus Infection GWAS Genetic Sequencing Guillain-Barré Influenza Neuritis Thrombocytopenia Vaccine Adverse Reaction Vaccine Reaction Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use Vasculitis

Interventions vaccinated

Updated 8 times since 2021 Last updated: Mar 3, 2022 Started: Mar 15, 2022 Primary completion: Apr 1, 2024 Completion: Apr 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05095844, this observational or N/A phase trial focuses on Blood Clot and COVID-19 and remains ongoing. Sponsored by Neuroganics LLC, it has been updated 8 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Apr 2022 — May 2024 [monthly]

Recruiting
Mar 2022 — Apr 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 3 earlier versions

Feb 2022 — Mar 2022 [monthly]

Not Yet Recruiting
Dec 2021 — Feb 2022 [monthly]

Not Yet Recruiting
Nov 2021 — Dec 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuroganics LLC
Ramos Injury Law Firm

Data source: Neuroganics LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Northglenn, United States